Dynamic multiprotein assemblies shape the spatial structure of cell signaling

Progress in Biophysics and Molecular Biology

Volumn 116, Issue 2-3, 2014, Pages 158-164

  Nussinov, Ruth ^a,b   Jang, Hyunbum ^a  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cell organization; Cell signaling; Cell structure; Diffusion; Signal transduction; Signaling modules

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; PROTEIN 14 3 3;

ANIMAL; CELL MEMBRANE; CELLS; CYTOLOGY; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

14-3-3 PROTEINS; ANIMALS; CELLS; HUMANS; MEMBRANE MICRODOMAINS; RAS GTPASE-ACTIVATING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84924080511     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2014.07.002     Document Type: Article

References (113)

1. Abraham S.J., Nolet R.P., Calvert R.J., Anderson L.M., Gaponenko V. The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin. Biochemistry 2009, 48:7575-7583.
2. Acuner Ozbabacan S.E., Gursoy A., Nussinov R., Keskin O. The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer. PLoS Comput. Biol. 2014, 10:e1003470.
3. Aitken A., Howell S., Jones D., Madrazo J., Martin H., Patel Y., Robinson K. Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase C. Mol. Cell. Biochem. 1995, 149-150:41-49.
4. Alvarez-Moya B., Barcelo C., Tebar F., Jaumot M., Agell N. CaM interaction and Ser181 phosphorylation as new K-Ras signaling modulators. Small GTPases 2011, 2:99-103.
5. Androulakis I.P., Kamisoglu K., Mattick J.S. Topology and dynamics of signaling networks: in search of transcriptional control of the inflammatory response. Annu. Rev. Biomed. Eng. 2013, 15:1-28.
6. Baljuls A., Schmitz W., Mueller T., Zahedi R.P., Sickmann A., Hekman M., Rapp U.R. Positive regulation of A-RAF by phosphorylation of isoform-specific hinge segment and identification of novel phosphorylation sites. J.Biol. Chem. 2008, 283:27239-27254.
7. Barcelo C., Paco N., Morell M., Alvarez-Moya B., Bota-Rabassedas N., Jaumot M., Vilardell F., Capella G., Agell N. Phosphorylation at Ser-181 of oncogenic KRAS is required for tumor growth. Cancer Res. 2014, 74:1190-1199.
8. Bolanos-Garcia V.M., Wu Q., Ochi T., Chirgadze D.Y., Sibanda B.L., Blundell T.L. Spatial and temporal organization of multi-protein assemblies: achieving sensitive control in information-rich cell-regulatory systems. Phil. Trans. Ser. Math. Phys. Eng. Sci. 2012, 370:3023-3039.
9. Bonnefoy-Berard N., Liu Y.C., von Willebrand M., Sung A., Elly C., Mustelin T., Yoshida H., Ishizaka K., Altman A. Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. Proc. Natl. Acad. Sci. U S A. 1995, 92:10142-10146.
10. Bozoky Z., Krzeminski M., Chong P.A., Forman-Kay J.D. Structural changes of CFTR R region upon phosphorylation: a plastic platform for intramolecular and intermolecular interactions. FEBS J. 2013, 280:4407-4416.
11. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
12. Cahill C.M., Tzivion G., Nasrin N., Ogg S., Dore J., Ruvkun G., Alexander-Bridges M. Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways. J.Biol. Chem. 2001, 276:13402-13410.
13. Cebecauer M., Spitaler M., Serge A., Magee A.I. Signalling complexes and clusters: functional advantages and methodological hurdles. J.Cell. Sci. 2010, 123:309-320.
14. Chan T.A., Hermeking H., Lengauer C., Kinzler K.W., Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999, 401:616-620.
15. Chavan T.S., Abraham S., Gaponenko V. Application of reductive (1)(3)C-methylation of lysines to enhance the sensitivity of conventional NMR methods. Molecules 2013, 18:7103-7119.
16. Chen B., Brinkmann K., Chen Z., Pak C.W., Liao Y., Shi S., Henry L., Grishin N.V., Bogdan S., Rosen M.K. The WAVE regulatory complex links diverse receptors to the actin cytoskeleton. Cell 2014, 156:195-207.
17. Chen Y., Wang Z., Wang Y. Spatiotemporal positioning of multipotent modules in diverse biological networks. Cell. Mol. Life Sci. 2014, 71(14):2605-2624.
18. Chetverina D., Aoki T., Erokhin M., Georgiev P., Schedl P. Making connections: insulators organize eukaryotic chromosomes into independent cis-regulatory networks. BioEssays News Rev. Mol. Cell. Dev. Biol. 2014, 36:163-172.
19. Chia P.H., Chen B., Li P., Rosen M.K., Shen K. Local F-actin network links synapse formation and axon branching. Cell 2014, 156:208-220.
20. Cho K.J., Kasai R.S., Park J.H., Chigurupati S., Heidorn S.J., van der Hoeven D., Plowman S.J., Kusumi A., Marais R., Hancock J.F. Raf inhibitors target ras spatiotemporal dynamics. Curr. Biol. CB 2012, 22:945-955.
21. Conklin D.S., Galaktionov K., Beach D. 14-3-3 proteins associate with cdc25 phosphatases. Proc. Natl. Acad. Sci. U S A 1995, 92:7892-7896.
22. Craparo A., Freund R., Gustafson T.A. 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J.Biol. Chem. 1997, 272:11663-11669.
23. Cui Q., Karplus M. Allostery and cooperativity revisited. Protein Sci. Publ. Protein Soc. 2008, 17:1295-1307.
24. del Sol A., Tsai C.J., Ma B., Nussinov R. The origin of allosteric functional modulation: multiple pre-existing pathways. Structure 2009, 17:1042-1050.
25. Dixit A., Verkhivker G.M. Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases. PLoS Comput. Biol. 2011, 7:e1002179.
26. Elias J., Dimitrio L., Clairambault J., Natalini R. The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate. Biochim. Biophys. Acta 2014, 1844:232-247.
27. Engin H.B., Gursoy A., Nussinov R., Keskin O. Network-based strategies can help mono- and poly-pharmacology drug discovery: a systems biology view. Curr. Pharm. Des. 2014, 20:1201-1207.
28. Fanger G.R., Widmann C., Porter A.C., Sather S., Johnson G.L., Vaillancourt R.R. 14-3-3 proteins interact with specific MEK kinases. J.Biol. Chem. 1998, 273:3476-3483.
29. Fantl W.J., Muslin A.J., Kikuchi A., Martin J.A., MacNicol A.M., Gross R.W., Williams L.T. Activation of Raf-1 by 14-3-3 proteins. Nature 1994, 371:612-614.
30. Fischer A., Baljuls A., Reinders J., Nekhoroshkova E., Sibilski C., Metz R., Albert S., Rajalingam K., Hekman M., Rapp U.R. Regulation of RAF activity by 14-3-3 proteins: RAF kinases associate functionally with both homo- and heterodimeric forms of 14-3-3 proteins. J.Biol. Chem. 2009, 284:3183-3194.
31. Freed E., Symons M., Macdonald S.G., McCormick F., Ruggieri R. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 1994, 265:1713-1716.
32. Fu H., Xia K., Pallas D.C., Cui C., Conroy K., Narsimhan R.P., Mamon H., Collier R.J., Roberts T.M. Interaction of the protein kinase Raf-1 with 14-3-3 proteins. Science 1994, 266:126-129.
33. Fu H., Subramanian R.R., Masters S.C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 2000, 40:617-647.
34. Furlanetto R.W., Dey B.R., Lopaczynski W., Nissley S.P. 14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor. Biochem. J. 1997, 327(Pt 3):765-771.
35. Grozinger C.M., Schreiber S.L. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. U S A 2000, 97:7835-7840.
36. Gunasekaran K., Ma B., Nussinov R. Is allostery an intrinsic property of all dynamic proteins?. Proteins 2004, 57:433-443.
37. Harding A., Hancock J.F. Ras nanoclusters: combining digital and analog signaling. Cell Cycle 2008, 7:127-134.
38. Harold F.M. Molecules into cells: specifying spatial architecture. Microbiol. Mol. Biol. Rev. MMBR 2005, 69:544-564.
39. Head B.P., Patel H.H., Insel P.A. Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling. Biochim. Biophys. Acta 2014, 1838:532-545.
40. Honda R., Ohba Y., Yasuda H. 14-3-3 zeta protein binds to the carboxyl half of mouse wee1 kinase. Biochem. Biophys. Res. Commun. 1997, 230:262-265.
41. Hou Y., He S., Ma C., Sun M., He H., Gao N. The merged basins of signal transduction pathways in spatiotemporal cell biology. J.Cell. Physiol. 2014, 229:287-291.
42. Irie K., Gotoh Y., Yashar B.M., Errede B., Nishida E., Matsumoto K. Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. Science 1994, 265:1716-1719.
43. Janosi L., Li Z., Hancock J.F., Gorfe A.A. Organization, dynamics, and segregation of Ras nanoclusters in membrane domains. Proc. Natl. Acad. Sci. U S A 2012, 109:8097-8102.
44. Jia P., Zhao Z. VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data. PLoS Comput. Biol. 2014, 10:e1003460.
45. Johnson C., Crowther S., Stafford M.J., Campbell D.G., Toth R., MacKintosh C. Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem. J. 2010, 427:69-78.
46. Kanai F., Marignani P.A., Sarbassova D., Yagi R., Hall R.A., Donowitz M., Hisaminato A., Fujiwara T., Ito Y., Cantley L.C., Yaffe M.B. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 2000, 19:6778-6791.
47. Kar G., Keskin O., Gursoy A., Nussinov R. Allostery and population shift in drug discovery. Curr. Opin. Pharmacol. 2010, 10:715-722.
48. Kenakin T., Miller L.J. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol. Rev. 2010, 62:265-304.
49. Konrath F., Witt J., Sauter T., Kulms D. Identification of new IkappaBalpha complexes by an iterative experimental and mathematical modeling approach. PLoS Comput. Biol. 2014, 10:e1003528.
50. Kostelecky B., Saurin A.T., Purkiss A., Parker P.J., McDonald N.Q. Recognition of an intra-chain tandem 14-3-3 binding site within PKCepsilon. EMBO Reports 2009, 10:983-989.
51. Kumar S., Ma B., Tsai C.J., Sinha N., Nussinov R. Folding and binding cascades: dynamic landscapes and population shifts. Protein Sci. Publ. Protein Soc. 2000, 9:10-19.
52. Kuzu G., Gursoy A., Nussinov R., Keskin O. Exploiting conformational ensembles in modeling protein-protein interactions on the proteome scale. J.Proteome Res. 2013, 12:2641-2653.
53. Laine E., Auclair C., Tchertanov L. Allosteric communication across the native and mutated KIT receptor tyrosine kinase. PLoS Comput. Biol. 2012, 8:e1002661.
54. Laronga C., Yang H.Y., Neal C., Lee M.H. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J.Biol. Chem. 2000, 275:23106-23112.
55. Lechtenberg B.C., Freund S.M., Huntington J.A. An ensemble view of thrombin allostery. Biol. Chem. 2012, 393:889-898.
56. Liao J., Omary M.B. 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J.Cell. Biol. 1996, 133:345-357.
57. Liu J., Nussinov R. Flexible cullins in cullin-RING E3 ligases allosterically regulate ubiquitination. J.Biol. Chem. 2011, 286:40934-40942.
58. Liu Y.C., Elly C., Yoshida H., Bonnefoy-Berard N., Altman A. Activation-modulated association of 14-3-3 proteins with Cbl in T cells. J.Biol. Chem. 1996, 271:14591-14595.
59. Long D., Bruschweiler R. Atomistic kinetic model for population shift and allostery in biomolecules. J.Am. Chem. Soc. 2011, 133:18999-19005.
60. Ma B., Nussinov R. Amplification of signaling via cellular allosteric relay and protein disorder. Proc. Natl. Acad. Sci. U S A 2009, 106:6887-6888.
61. Ma B., Kumar S., Tsai C.J., Nussinov R. Folding funnels and binding mechanisms. Protein Eng. 1999, 12:713-720.
62. Ma B., Shatsky M., Wolfson H.J., Nussinov R. Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations. Protein Sci. Publ. Protein Soc. 2002, 11:184-197.
63. Ma B., Tsai C.J., Pan Y., Nussinov R. Why does binding of proteins to DNA or proteins to proteins not necessarily spell function?. ACS Chem. Biol. 2010, 5:265-272.
64. Malarkannan S., Awasthi A., Rajasekaran K., Kumar P., Schuldt K.M., Bartoszek A., Manoharan N., Goldner N.K., Umhoefer C.M., Thakar M.S. IQGAP1: a regulator of intracellular spacetime relativity. J.Immunol. 2012, 188:2057-2063.
65. Mattila P.K., Feest C., Depoil D., Treanor B., Montaner B., Otipoby K.L., Carter R., Justement L.B., Bruckbauer A., Batista F.D. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling. Immunity 2013, 38:461-474.
66. McLaughlin R.N., Poelwijk F.J., Raman A., Gosal W.S., Ranganathan R. The spatial architecture of protein function and adaptation. Nature 2012, 491:138-142.
67. Minde D.P., Anvarian Z., Rudiger S.G., Maurice M.M. Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer?. Mol. Cancer 2011, 10:101.
68. Molnar E., Swamy M., Holzer M., Beck-Garcia K., Worch R., Thiele C., Guigas G., Boye K., Luescher I.F., Schwille P., Schubert R., Schamel W.W. Cholesterol and sphingomyelin drive ligand-independent T-cell antigen receptor nanoclustering. J.Biol. Chem. 2012, 287:42664-42674.
69. Nagata K., Puls A., Futter C., Aspenstrom P., Schaefer E., Nakata T., Hirokawa N., Hall A. The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3. EMBO J. 1998, 17:149-158.
70. Nibbs R.J., Graham G.J. Immune regulation by atypical chemokine receptors. Nat. Rev. Immunol. 2013, 13:815-829.
71. Nussinov R. How do dynamic cellular signals travel long distances?. Mol. Biosyst. 2012, 8:22-26.
72. Nussinov R. The spatial structure of cell signaling systems. Phys. Biol. 2013, 10:045004.
73. Nussinov R., Tsai C.J., Xin F., Radivojac P. Allosteric post-translational modification codes. Trends Biochem. Sci. 2012, 37:447-455.
74. Nussinov R., Ma B., Tsai C.J. Abroad view of scaffolding suggests that scaffolding proteins can actively control regulation and signaling of multienzyme complexes through allostery. Biochim. Biophys. Acta 2013, 1834:820-829.
75. Nussinov R., Ma B., Tsai C.J., Csermely P. Allosteric conformational barcodes direct signaling in the cell. Structure 2013, 21:1509-1521.
76. Nussinov R., Tsai C.J., Ma B. The underappreciated role of allostery in the cellular network. Annu. Rev. Biophys. 2013, 42:169-189.
77. Ogihara T., Isobe T., Ichimura T., Taoka M., Funaki M., Sakoda H., Onishi Y., Inukai K., Anai M., Fukushima Y., Kikuchi M., Yazaki Y., Oka Y., Asano T. 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J.Biol. Chem. 1997, 272:25267-25274.
78. Pallas D.C., Fu H., Haehnel L.C., Weller W., Collier R.J., Roberts T.M. Association of polyomavirus middle tumor antigen with 14-3-3 proteins. Science 1994, 265:535-537.
79. Pandini A., Fornili A., Fraternali F., Kleinjung J. Detection of allosteric signal transmission by information-theoretic analysis of protein dynamics. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2012, 26:868-881.
80. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997, 277:1501-1505.
81. Pietromonaco S.F., Seluja G.A., Aitken A., Elias L. Association of 14-3-3 proteins with centrosomes. Blood Cells Mol. Dis. 1996, 22:225-237.
82. Resendis-Antonio O., Hernandez M., Mora Y., Encarnacion S. Functional modules, structural topology, and optimal activity in metabolic networks. PLoS Comput. Biol. 2012, 8:e1002720.
83. Reuther G.W., Fu H., Cripe L.D., Collier R.J., Pendergast A.M. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family. Science 1994, 266:129-133.
84. Riou P., Kjaer S., Garg R., Purkiss A., George R., Cain R.J., Bineva G., Reymond N., McColl B., Thompson A.J., O'Reilly N., McDonald N.Q., Parker P.J., Ridley A.J. 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. Cell 2013, 153:640-653.
85. Rivalta I., Sultan M.M., Lee N.S., Manley G.A., Loria J.P., Batista V.S. Allosteric pathways in imidazole glycerol phosphate synthase. Proc. Natl. Acad. Sci. U S A 2012, 109:E1428-E1436.
86. Roy S., Lagree S., Hou Z., Thomson J.A., Stewart R., Gasch A.P. Integrated module and gene-specific regulatory inference implicates upstream signaling networks. PLoS Comput. Biol. 2013, 9:e1003252.
87. Sanchez-Soria P., Camenisch T.D. ErbB signaling in cardiac development and disease. Seminars Cell. Dev. Biol. 2010, 21:929-935.
88. Seshacharyulu P., Ponnusamy M.P., Haridas D., Jain M., Ganti A.K., Batra S.K. Targeting the EGFR signaling pathway in cancer therapy. Expert Opin. Ther. Targets 2012, 16:15-31.
89. Shan Q., Han L., Lynch J.W. Function of hyperekplexia-causing alpha1R271Q/L glycine receptors is restored by shifting the affected residue out of the allosteric signalling pathway. Br. J. Pharmacol. 2012, 165:2113-2123.
90. Shreif Z., Periwal V. Anetwork characteristic that correlates environmental and genetic robustness. PLoS Comput. Biol. 2014, 10:e1003474.
91. Sohn Y., Choi M.K., Ahn Y.Y., Lee J., Jeong J. Topological cluster analysis reveals the systemic organization of the Caenorhabditis elegans connectome. PLoS Comput. Biol. 2011, 7:e1001139.
92. Soldevilla B., Millan C.S., Bonilla F., Dominguez G. The TP73 complex network: ready for clinical translation in cancer?. Genes. Chrom. Cancer 2013, 52:989-1006.
93. Song J., Singh M. From hub proteins to hub modules: the relationship between essentiality and centrality in the yeast interactome at different scales of organization. PLoS Comput. Biol. 2013, 9:e1002910.
94. Tang S.J., Suen T.C., McInnes R.R., Buchwald M. Association of the TLX-2 homeodomain and 14-3-3eta signaling proteins. J.Biol. Chem. 1998, 273:25356-25363.
95. Tinti M., Madeira F., Murugesan G., Hoxhaj G., Toth R., Mackintosh C. ANIA: annotation and integrated analysis of the 14-3-3 interactome. Database J. Biol. Databases Curation 2014, 2014:bat085.
96. Tsai C.J., Kumar S., Ma B., Nussinov R. Folding funnels, binding funnels, and protein function. Protein Sci. Publ. Protein Soc. 1999, 8:1181-1190.
97. Tsai C.J., Ma B., Nussinov R. Folding and binding cascades: shifts in energy landscapes. Proc. Natl. Acad. Sci. U S A 1999, 96:9970-9972.
98. Tsai C.J., Ma B., Sham Y.Y., Kumar S., Nussinov R. Structured disorder and conformational selection. Proteins 2001, 44:418-427.
99. Tsai C.J., del Sol A., Nussinov R. Allostery: absence of a change in shape does not imply that allostery is not at play. J.Mol. Biol. 2008, 378:1-11.
100. Tsai C.J., Del Sol A., Nussinov R. Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms. Mol. Biosyst. 2009, 5:207-216.
101. Tyanova S., Cox J., Olsen J., Mann M., Frishman D. Phosphorylation variation during the cell cycle scales with structural propensities of proteins. PLoS Comput. Biol. 2013, 9:e1002842.
102. Tzeng S.R., Kalodimos C.G. Protein dynamics and allostery: an NMR view. Curr. Opin. Struct. Biol. 2011, 21:62-67.
103. Tzivion G., Luo Z.J., Avruch J. Calyculin A-induced vimentin phosphorylation sequesters 14-3-3 and displaces other 14-3-3 partners invivo. J.Biol. Chem. 2000, 275:29772-29778.
104. Tzivion G., Shen Y.H., Zhu J. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 2001, 20:6331-6338.
105. Vetterkind S., Poythress R.H., Lin Q.Q., Morgan K.G. Hierarchical scaffolding of an ERK1/2 activation pathway. Cell. Commun. Signal. CCS 2013, 11:65.
106. Wang A.H., Kruhlak M.J., Wu J., Bertos N.R., Vezmar M., Posner B.I., Bazett-Jones D.P., Yang X.J. Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell. Biol. 2000, 20:6904-6912.
107. Waterman M.J., Stavridi E.S., Waterman J.L., Halazonetis T.D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 1998, 19:175-178.
108. Welz T., Wellbourne-Wood J., Kerkhoff E. Orchestration of cell surface proteins by Rab11. Trends Cell. Biol. 2014, 24(7):407-415.
109. White C.D., Erdemir H.H., Sacks D.B. IQGAP1 and its binding proteins control diverse biological functions. Cell. Signal. 2012, 24:826-834.
110. Xiao B., Smerdon S.J., Jones D.H., Dodson G.G., Soneji Y., Aitken A., Gamblin S.J. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 1995, 376:188-191.
111. Zhang L., Wang H., Masters S.C., Wang B., Barbieri J.T., Fu H. Residues of 14-3-3 zeta required for activation of exoenzyme S of Pseudomonas aeruginosa. Biochemistry 1999, 38:12159-12164.
112. Zhang H., Koo C.Y., Stebbing J., Giamas G. The dual function of KSR1: a pseudokinase and beyond. Biochem. Soc. Trans. 2013, 41:1078-1082.
113. Zhuravlev P.I., Papoian G.A. Protein functional landscapes, dynamics, allostery: a tortuous path towards a universal theoretical framework. Q.Rev. Biophys. 2010, 43:295-332.